Please Wait
Applying Filters...
menu
    • menu
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Lee Pharma Ltd: Global supplier of certified APIs and formulations, driven by innovation and regulatory excellence.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Ethypharm is an international Pharma company with European roots manufacturing and commercializing essential drugs all over the world.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    Menu

    XC001

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    XyloCor Therapeutics Dose First Patient in Phase 2b EXACT-2 Trial
    XyloCor Therapeutics Dose First Patient in Phase 2b EXACT-2 Trial

    10 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250710062216/en/First-Patient-Dosed-in-XyloCor-Therapeutics-Phase-2b-EXACT-2-Trial-Evaluating-XC001-for-the-Treatment-of-Coronary-Artery-Disease

    BUSINESSWIRE
    10 Jul 2025
    Share Share
    XyloCor's XC001 Positive EXACT Phase 2 Data Presented, Published
    XyloCor's XC001 Positive EXACT Phase 2 Data Presented, Published

    02 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240501532555/en

    BUSINESSWIRE
    02 May 2024
    Share Share
    XyloCor hires Reinhardt as CMO to lead gene therapy programs
    XyloCor hires Reinhardt as CMO to lead gene therapy programs

    07 Aug 2019

    // Nick Paul Taylor FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/xylocor-hires-reinhardt-as-cmo-to-lead-gene-therapy-programs

    Nick Paul Taylor FIERCE BIOTECH
    07 Aug 2019
    Share Share